Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543(7643):15.
Article
CAS
Google Scholar
Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Diseases Society of America guidance on the treatment of extended-spectrum beta-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis. 2021;72(7):1109–16.
Article
Google Scholar
Karampatakis T, Tsergouli K, Iosifidis E, Antachopoulos C, Karapanagiotou A, Karyoti A, et al. Impact of active surveillance and infection control measures on carbapenem-resistant gram-negative bacterial colonization and infections in intensive care. J Hosp Infect. 2018;99(4):396–404.
Article
CAS
Google Scholar
Gandra S, Ellison RT 3rd. Modern trends in infection control practices in intensive care units. J Intensive Care Med. 2014;29(6):311–26.
Article
Google Scholar
Liang Q, Yan C, Xu Z, Huang M. Preemptive isolation and active surveillance in the prevention and control of nosocomial infection reduce the incidence of carbapenem-resistant Enterobacteriaceae. Infect Dis (Lond). 2019;51(5):377–9.
Article
Google Scholar
Tang SSL, Chee E, Teo JQ, Chlebicki MP, Kwa ALH. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study. (1872–7913 (Electronic)).
Asensio A, Cantero M, Shaw E, Vergara-Lopez S. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system. Enferm Infecc Microbiol Clin. 2014;32(Suppl 4):61–6.
Article
Google Scholar
Niederman MS, Alder J, Bassetti M, Boateng F, Cao B, Corkery K, et al. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial. Lancet Infect Dis. 2020;20(3):330–40.
Article
CAS
Google Scholar
Xu F, He LL, Che LQ, Li W, Ying SM, Chen ZH, et al. Aerosolized antibiotics for ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis. Crit Care. 2018;22(1):301.
Article
Google Scholar
De Waele JJ, Martin-Loeches I. Optimal duration of antibiotic treatment in gram-negative infections. Curr Opin Infect Dis. 2018;31(6):606–11.
Article
Google Scholar
Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015;70(7):2133–43.
Article
CAS
Google Scholar
Gutierrez-Gutierrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Pano-Pardo JR, et al. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis. 2017;17(7):726–34.
Article
Google Scholar
Bedos JP, Daikos G, Dodgson AR, Pan A, Petrosillo N, Seifert H, et al. Early identification and optimal management of carbapenem-resistant gram-negative infection. J Hosp Infect. 2021;108:158–67.
Article
CAS
Google Scholar
Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases Society of America and the American Thoracic Society. (1537–6591 (Electronic)).
Hooton TM, Bradley Sf Fau-Cardenas DD, Cardenas Dd Fau-Colgan R, Colgan R Fau-Geerlings SE, Geerlings Se Fau-Rice JC, Rice Jc Fau-Saint S, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases Society of America. (1537–6591 (Electronic)).
Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, et al. Infectious diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. 2017. (1537–6591 (Electronic)).
Solomkin JS, Mazuski Je Fau-Bradley JS, Bradley Js Fau-Rodvold KA, Rodvold Ka Fau-Goldstein EJC, Goldstein Ej Fau-Baron EJ, Baron Ej Fau-O'Neill PJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. (1537–6591 (Electronic)).
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. (1537–6591 (Electronic)).
Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, et al. 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. (1537–6591 (Electronic)).
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–84.
Article
Google Scholar
Thatrimontrichai A, Apisarnthanarak A. Active surveillance culture program in asymptomatic patients as a strategy to control multidrug-resistant gram-negative organisms: What should be considered? J Formos Med Assoc. 2020;119(11):1581–5.
Article
Google Scholar
Tischendorf J, de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: a systematic review. Am J Infect Control. 2016;44(5):539–43.
Article
Google Scholar
Burillo A, Munoz P, Bouza E. Risk stratification for multidrug-resistant gram-negative infections in ICU patients. Curr Opin Infect Dis. 2019;32(6):626–37.
Article
CAS
Google Scholar
Song JY, Jeong IS. Validation of a carbapenem-resistant Enterobacteriaceae colonization risk prediction model: a retrospective cohort study in Korean intensive care units. (1527–3296 (Electronic)).
Goodman KA-OX, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Toerper MF, et al. Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission. (1559–6834 (Electronic)).
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–67.
Article
Google Scholar
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10.
Article
CAS
Google Scholar
Carrara E, Pfeffer I, Zusman O, Leibovici L, Paul M. Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis. (1872–7913 (Electronic)).
Zak-Doron Y, Dishon Benattar Y, Pfeffer I, Daikos GL, Skiada A, Antoniadou A, et al. The association between empirical antibiotic treatment and mortality in severe infections caused by carbapenem-resistant gram-negative bacteria: a prospective study. Clin Infect Dis. 2018;67(12):1815–23.
CAS
PubMed
Google Scholar